<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-VLZ7JG2L</identifier><date>2016</date><creator>Hodolič, Marina</creator><creator>Pichler, Robert</creator><creator>Topakian, Raffi</creator><relation>documents/doc/V/URN_NBN_SI_doc-VLZ7JG2L_001.pdf</relation><relation>documents/doc/V/URN_NBN_SI_doc-VLZ7JG2L_001.txt</relation><format format_type="issue">3</format><format format_type="volume">50</format><format format_type="type">article</format><format format_type="extent">str. 247-253, I</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">3043756</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-VLZ7JG2L</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">18F-FDG</subject><subject language_type_id="slv">18F-Flumazenil</subject><subject language_type_id="slv">epilepsija</subject><subject language_type_id="eng">epilepsy</subject><subject language_type_id="eng">nuclear medicine</subject><subject language_type_id="slv">nuklearna medicina</subject><subject language_type_id="slv">PET/CT</subject><subject language_type_id="slv">radioterapija</subject><title>18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy</title></Record>